Mirae Asset Global Investments
NUTX

Mirae Asset Global Investments’s Nutex Health NUTX Stock Holding History

Mirae Asset Global Investments’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-74
Closed -$36K – 2642
2022
Q2 		$36K Buy
+74
New +$87.2K ﹤0.01% 2390

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EWP
Engrave Wealth Partners The Woodlands, Texas $350M AUM 13.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mirae Asset Global Investments's NUTX Position: Q3 2022 in Review

Mirae Asset Global Investments sold out of Nutex Health (NUTX) in Q3 2022, closing a stake of 74 shares — an estimated $36K sold.

Mirae Asset Global Investments first reported a position in NUTX in Q2 2022 and held it in 1 quarter. The position peaked at $36K in Q2 2022. 51 funds tracked by Wall St. Rank hold NUTX as of Q3 2022.

  • Mirae Asset Global Investments reported no remaining Nutex Health position as of Q3 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 74 Nutex Health shares in Q3 2022, an estimated $36K.
  • Mirae Asset Global Investments first reported a position in Nutex Health in Q2 2022 and held it in 1 quarter.
  • Mirae Asset Global Investments's Nutex Health position peaked at $36K in Q2 2022.
  • 51 funds tracked by Wall St. Rank held Nutex Health as of Q3 2022.

Based on Mirae Asset Global Investments's 13F filing for Q3 2022, filed 10 Nov 2022.